Abstract: An arrangement for adding a first fluid component into a flow system, said arrangement comprising: a first pump provided in a first component adding fluid line which is connecting a first system fluid line of the flow system with a first fluid component source comprising the first fluid component to be added into the flow system; and a second pump provided in a second component adding fluid line connected in parallel with the first component adding fluid line, said second component adding fluid line connecting the first system fluid line of the flow system with a first fluid component source comprising the first fluid component to be added into the flow system.
Abstract: The present invention relates to a diagnostic device (400) for measuring component performance on an automated radiopharmaceutical synthesis device (50).
Abstract: The present invention relates to the field of radioactive substances and in particular to a method to facilitate handling of radioactive solutions. Provided by the present invention is a device that enables preparation of capsules filled with radioactivity. More particularly, the radioactivity is suitable for use in certain radiopharmaceutical procedures. The present invention provides improved accuracy and uniformity of patient doses. Furthermore, the potential for spills and needle stick injuries is reduced and the radiation burden is reduced.
Abstract: A fluidic device is disclosed for processing a biological sample in order to extract nucleic acids contained in said sample and for subsequently amplifying said extracted nucleic acids, said device including a processed sample storage archive area 10 comprising an absorbent solid substrate 14 treated with at least one nucleic acid stabilizing reagent or reagent mix, said substrate allowing the generally dry and stabilized storage of said extracted and/or amplified nucleic acids, for example for long term storage of biological samples recovered forensically.
Abstract: A chromatography column having a longitudinal axis and comprising a column wall with a first end and a second end, a first end plate assembly removably connectable to said first end of the column wall, a second end plate assembly removably connectable to said second end of the column wall, wherein said first end plate assembly, said column wall and said second end plate assembly are arranged along the longitudinal axis of the column wherein the column wall, and/or first end plate assembly and/or second end plate assembly is/are rotatable about an axis of rotation wherein said axis of rotation is parallel to the longitudinal axis of said column and positioned outside the column.
Type:
Grant
Filed:
April 4, 2016
Date of Patent:
August 27, 2019
Assignee:
GE HEALTHCARE BIO-SCIENCES AB
Inventors:
Per Lofving, Mats Olsson, Sven Wounder, Jerker Persson
Abstract: A holding system for holding and hoisting a chromatography column of one or more chromatography columns is disclosed. The holding system includes an upright member and a plurality of holding members movably arranged along the upright member. A first supporting member is positioned at an end portion of the chromatography column, wherein a holding member of the plurality of holding members is configured to be engaged to the first supporting member. A second supporting member is positioned at another end portion of the chromatography column. A holding member of the plurality of holding members is configured to be engaged to the second supporting member. One or more hoist assisting members may be also present. A hoist assisting member is operatively connected to the holding member engaged to the first supporting member. The hoist assisting member is operable to move the holding member connected to the first supporting member for hoisting the chromatography column.
Abstract: A method for controlling at least one culture parameter in a bioreactor bag (1; 31a, 31b) provided in a bioreactor system, said method comprising the steps of: providing bioreactor information to a control unit (5; 35) controlling the bioreactor system; controlling the at least one culture parameter in dependence of the bioreactor information.
Type:
Application
Filed:
April 30, 2019
Publication date:
August 22, 2019
Applicant:
GE HEALTHCARE BIO-SCIENCES AB
Inventors:
Klaus Gebauer, Eva Lindskog, Lars Magnusson
Abstract: The present invention relates to a method for the determination of chromatography conditions for the separation of a biomolecule from a liquid sample, which method comprises selecting a number of experiments using design of experiments (DoE); performing said experiments with in-line conditioning of orthogonal quality measures; and based on the results from the experiments, determining efficient chromatography conditions for said biomolecule. The invention also relates to a system for performing the method as well as a computer program and an instrument comprising such a computer program.
Type:
Grant
Filed:
June 3, 2016
Date of Patent:
August 13, 2019
Assignee:
GE HEALTHCARE BIO-SCIENCES AB
Inventors:
Enrique Napoleon Carredano, Gustav Jose Rodrigo
Abstract: The present invention relates to a method for removal of large contaminants, such as virus, in a chromatographic process for purification of a target molecule, preferably monoclonal antibodies, mAbs, by using a specifically designed chromatographic bead having a thin outer layer and a core functionalized with a ligand adsorbing the mAbs or parts thereof.
Type:
Application
Filed:
April 17, 2019
Publication date:
August 8, 2019
Applicant:
GE Healthcare BioProcess R&D AB
Inventors:
Jean-Luc Maloisel, Ola Lind, Bjorn Noren, Ronnie Palmgren
Abstract: The present disclosure relates to a manufacturing system, method and control circuitry for quality assured manufacturing of at least two biopharmaceutical products. The manufacturing system comprises a warehouse facility, a hydration facility, and at least two biopharmaceutical manufacturing facilities, wherein the warehouse facility and hydration facility are comprised in the macro structure. Each biopharmaceutical manufacturing facility is comprised in a respective micro node, and a control facility in the macro structure is configured to control interoperability of the macro structure and the micro nodes by means of a network spine interconnecting the macro structure with each micro node.
Type:
Grant
Filed:
August 29, 2016
Date of Patent:
August 6, 2019
Assignee:
GE Healthcare Bio-Sciences Corp.
Inventors:
Steve Robert Gravallese, Jason Naylor, Edwin Brian Taylor, Sven Frie, Patrick McMahon
Abstract: The present invention relates to the field of nucleic acid collection and storage, and in particular to the collection and long-term storage of nuclei. The invention provides a device and method which can be used to capture and store nuclei at ambient temperatures allowing the subsequent isolation of nucleic acids by passive washing with a wash buffer. The present invention also provides a kit including the device of the invention suitable for carrying out the method of the invention.
Type:
Grant
Filed:
June 17, 2015
Date of Patent:
August 6, 2019
Assignee:
GE Healthcare UK Limited
Inventors:
Michael Kenneth Kenrick, Geraint Seymour
Abstract: The invention discloses a cellulose or glass fiber paper for preservation of biological samples, which comprises 4-30 wt % of a hydrophilic branched carbohydrate polymer. It also discloses a method for preservation of biological samples by applying and drying them on the paper.
Type:
Grant
Filed:
October 29, 2012
Date of Patent:
August 6, 2019
Assignee:
GE Healthcare Bio-Sciences AB
Inventors:
Mattias Algotsson, Miles W. Burrows, Jimmy Hedin Dahlstrom, Ylva Laurin, Ronnie Palmgren, Jinyu Zou
Abstract: A process for preparing a composition comprising encapsulated gas microbubbles, the process comprising: providing an aqueous protein solution of a heat-denaturable protein at a temperature necessary to achieve incipient denaturation; heating a gas by using heat from the heated protein solution; mixing the heated gas and the heated protein solution to obtain a gas/liquid mixture; and dispersing the gas into the protein solution by subjecting the gas/liquid mixture to mechanical shear forces to form a composition of gas microbubbles encapsulated by denatured protein.
Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
Type:
Grant
Filed:
November 13, 2018
Date of Patent:
July 9, 2019
Assignee:
GE HEALTHCARE BIOPROCESS R&D AB
Inventors:
Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg